Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T80306 | Target Info | |||
Target Name | S-phase kinase-associated protein 2 (SKP2) | ||||
Synonyms | Skp2; P45skp2; FBXL1; F-box/LRR-repeat protein 1; F-box protein Skp2; Cyclin-A/CDK2-associated protein p45; Cyclin A/CDK2-associated protein p45; Cyclin A/CDK2-associated p45 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | SKP2 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Biochemical Activity | [4] | |||
Beta-transducin repeats | [+] 2 Beta-transducin repeats | + | |||
Interacting Protein Name | Fizzy-related protein homolog (FZR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDC20C; CDH1; FZR; FZR2; HCDH; HCDH1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Affinity Capture-Western | [7] | |||
4 | Affinity Capture-Western | [8] | |||
5 | Reconstituted Complex | [6] | |||
6 | Reconstituted Complex | [1] | |||
Interacting Protein Name | Cell division cycle protein 20 homolog (CDC20) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDC20A; bA276H19.3; p55CDC | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [7] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | NAD-dependent deacetylase sirtuin-3 (SIRT3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIR2-like protein 3; SIR2L3; Regulatory protein SIR2 homolog 3; hSIRT3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Reconstituted Complex | [1] | |||
Cell cycle related proteins | [+] 2 Cell cycle related proteins | + | |||
Interacting Target Name | Cyclin A2 (CCNA2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [11] | |||
3 | Affinity Capture-Western | [12] | |||
4 | Affinity Capture-Western | [13] | |||
5 | Affinity Capture-Western | [14] | |||
6 | Reconstituted Complex | [15] | |||
Interacting Protein Name | Cyclin-A1 (CCNA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CT146 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Reconstituted Complex | [16] | |||
Cullins | [+] 1 Cullins | + | |||
Interacting Protein Name | Cullin-1 (CUL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-MS | [17] | |||
3 | Affinity Capture-Western | [18] | |||
4 | Affinity Capture-Western | [19] | |||
5 | Affinity Capture-Western | [20] | |||
6 | Affinity Capture-Western | [21] | |||
7 | Affinity Capture-Western | [22] | |||
8 | Affinity Capture-Western | [23] | |||
9 | Affinity Capture-Western | [24] | |||
10 | Affinity Capture-Western | [25] | |||
11 | Affinity Capture-Western | [26] | |||
12 | Affinity Capture-Western | [16] | |||
13 | Affinity Capture-Western | [14] | |||
14 | Affinity Capture-Western | [27] | |||
15 | Affinity Capture-Western | [28] | |||
16 | Affinity Capture-Western | [29] | |||
17 | Affinity Capture-Western | [30] | |||
18 | Affinity Capture-Western | [31] | |||
19 | Affinity Capture-Western | [32] | |||
20 | Affinity Capture-Western | [33] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Affinity Capture-Western | [14] | |||
4 | Affinity Capture-Western | [11] | |||
5 | Affinity Capture-Western | [8] | |||
6 | Affinity Capture-Western | [1] | |||
7 | Co-crystal Structure | [34] | |||
8 | Reconstituted Complex | [15] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Affinity Capture-Western | [19] | |||
3 | Affinity Capture-Western | [35] | |||
4 | Biochemical Activity | [36] | |||
5 | Co-localization | [19] | |||
6 | Reconstituted Complex | [19] | |||
Transcription regulators | [+] 4 Transcription regulators | + | |||
Interacting Target Name | Forkhead box protein O1A (FOXO1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FOXO1A; Forkhead in rhabdomyosarcoma; Forkhead box protein O1A; Forkhead box protein O1; FKHR | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [37] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [38] | |||
4 | Reconstituted Complex | [37] | |||
Interacting Target Name | Proto-oncogene c-Myc (MYC) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor p64; Proto-oncogene c-Myc; Myc proto-oncogene protein; C-myc oncogene; C-myc; Class E basic helix-loop-helix protein 39; bHLHe39 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Protein-Fragment Complementation Assay | [39] | |||
3 | Reconstituted Complex | [39] | |||
Interacting Target Name | E2F transcription factor 1 (E2F1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor E2F1; Retinoblastoma-binding protein 3; Retinoblastoma-associated protein 1; RBBP-3; RBBP3; RBAP-1; pRB-binding protein E2F-1; PBR3; E2F-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Reconstituted Complex | [15] | |||
Interacting Protein Name | Forkhead box protein O3 (FOXO3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AF6q21; FKHRL1; FKHRL1P2; FOXO2; FOXO3A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Biochemical Activity | [41] | |||
Other proteins | [+] 8 Other proteins | + | |||
Interacting Protein Name | S-phase kinase-associated protein 1 (SKP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EMC19; OCP.II; OCP2; SKP1A; TCEB1L; p19A | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [17] | |||
2 | Affinity Capture-MS | [42] | |||
3 | Affinity Capture-Western | [18] | |||
4 | Affinity Capture-Western | [19] | |||
5 | Affinity Capture-Western | [20] | |||
6 | Affinity Capture-Western | [43] | |||
7 | Affinity Capture-Western | [22] | |||
8 | Affinity Capture-Western | [23] | |||
9 | Affinity Capture-Western | [25] | |||
10 | Affinity Capture-Western | [36] | |||
11 | Affinity Capture-Western | [14] | |||
12 | Affinity Capture-Western | [44] | |||
13 | Affinity Capture-Western | [45] | |||
14 | Affinity Capture-Western | [27] | |||
15 | Affinity Capture-Western | [28] | |||
16 | Affinity Capture-Western | [29] | |||
17 | Affinity Capture-Western | [30] | |||
18 | Affinity Capture-Western | [46] | |||
19 | Affinity Capture-Western | [47] | |||
20 | Affinity Capture-Western | [48] | |||
Interacting Target Name | CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p27Kip1; KIP1; Cyclin-dependent kinase inhibitor p27; Cyclindependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Affinity Capture-Western | [23] | |||
4 | Affinity Capture-Western | [14] | |||
5 | Affinity Capture-Western | [49] | |||
6 | Affinity Capture-Western | [27] | |||
7 | Affinity Capture-Western | [28] | |||
8 | Affinity Capture-Western | [29] | |||
9 | Biochemical Activity | [50] | |||
10 | Biochemical Activity | [22] | |||
11 | Biochemical Activity | [51] | |||
12 | Biochemical Activity | [36] | |||
13 | Biochemical Activity | [16] | |||
14 | Biochemical Activity | [14] | |||
15 | Biochemical Activity | [7] | |||
16 | Biochemical Activity | [52] | |||
17 | Biochemical Activity | [53] | |||
18 | Biochemical Activity | [30] | |||
19 | Biochemical Activity | [54] | |||
20 | Biochemical Activity | [55] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [56] | |||
2 | Affinity Capture-Western | [57] | |||
3 | Affinity Capture-Western | [8] | |||
4 | Affinity Capture-Western | [45] | |||
5 | Biochemical Activity | [58] | |||
6 | Biochemical Activity | [59] | |||
7 | Biochemical Activity | [45] | |||
8 | Co-localization | [60] | |||
Interacting Protein Name | Cyclin-dependent kinases regulatory subunit 1 (CKS1B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CKS1; PNAS.16; PNAS.18; ckshs1 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [61] | |||
2 | Affinity Capture-Western | [22] | |||
3 | Fluorescence Resonance Energy Transfer | [62] | |||
4 | Reconstituted Complex | [63] | |||
5 | Reconstituted Complex | [52] | |||
6 | Reconstituted Complex | [53] | |||
7 | Reconstituted Complex | [64] | |||
8 | Reconstituted Complex | [65] | |||
Interacting Protein Name | Protein BTG2 (BTG2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PC3; TIS21 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [66] | |||
2 | Affinity Capture-Western | [67] | |||
3 | Reconstituted Complex | [67] | |||
Interacting Protein Name | DNA replication factor Cdt1 (CDT1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DUP; RIS2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [68] | |||
2 | Affinity Capture-Western | [31] | |||
3 | Biochemical Activity | [31] | |||
Interacting Target Name | Epithelial cadherin (CDH1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Uvomorulin; UVO; E-cadherin gene; E-cadherin; CDHE; CD324; CAM 120/80; Cadherin-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [69] | |||
2 | Biochemical Activity | [44] | |||
Interacting Target Name | CDK inhibitor 1C p57Kip2 (CDKN1C) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P57KIP2; P57(KIP2); KIP2; Cyclin-dependent kinase inhibitor p57; Cyclin-dependent kinase inhibitor 1C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Biochemical Activity | [70] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Acetylation-dependent regulation of Skp2 function. Cell. 2012 Jul 6;150(1):179-93. | ||||
REF 2 | A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis. Angew Chem Int Ed Engl. 2016 Jan 11;55(2):602-6. | ||||
REF 3 | The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. J Biol Chem. 2012 Nov 30;287(49):41014-22. | ||||
REF 4 | Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection. Cell Cycle. 2015;14(3):437-48. | ||||
REF 5 | SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression. Cell Rep. 2013 Aug 29;4(4):803-16. | ||||
REF 6 | Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol. 2009 Apr;11(4):397-408. | ||||
REF 7 | Regulation of Skp2 levels by the Pim-1 protein kinase. J Biol Chem. 2010 Sep 17;285(38):29128-37. | ||||
REF 8 | SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology. 2009 Nov;137(5):1816-26.e1-10. | ||||
REF 9 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 10 | SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol Cell Biol. 2012 Dec;32(24):5022-34. | ||||
REF 11 | Skp2 inversely correlates with p27 and tuberin in transformed cells. Amino Acids. 2009 Jul;37(2):257-62. | ||||
REF 12 | Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation. Mol Cell Endocrinol. 2017 Jan 5;439:1-9. | ||||
REF 13 | Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J Biol Chem. 2004 Nov 19;279(47):48707-15. | ||||
REF 14 | Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization. Cell Cycle. 2010 Mar 1;9(5):971-4. | ||||
REF 15 | Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol. 1999 May;1(1):14-9. | ||||
REF 16 | Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1. J Biol Chem. 2006 Aug 18;281(33):24058-69. | ||||
REF 17 | Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein. Mol Cell Biol. 2006 Aug;26(16):5994-6004. | ||||
REF 18 | PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth. Nature. 2017 Jun 22;546(7659):554-558. | ||||
REF 19 | Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol. 2009 Apr;11(4):420-32. | ||||
REF 20 | Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell. 2012 May 11;46(3):351-61. | ||||
REF 21 | Fbxo45 inhibits calcium-sensitive proteolysis of N-cadherin and promotes neuronal differentiation. J Biol Chem. 2014 Oct 10;289(41):28448-59. | ||||
REF 22 | Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase. EMBO J. 2008 Feb 20;27(4):679-91. | ||||
REF 23 | SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999 Aug;1(4):193-9. | ||||
REF 24 | Characterization of the role of COP9 signalosome in regulating cullin E3 ubiquitin ligase activity. Mol Biol Cell. 2011 Dec;22(24):4706-15. | ||||
REF 25 | TIP120A associates with cullins and modulates ubiquitin ligase activity. J Biol Chem. 2003 May 2;278(18):15905-10. | ||||
REF 26 | Substrate-mediated regulation of cullin neddylation. J Biol Chem. 2007 Jun 8;282(23):17032-40. | ||||
REF 27 | Substrate binding promotes formation of the Skp1-Cul1-Fbxl3 (SCF(Fbxl3)) protein complex. J Biol Chem. 2013 Nov 8;288(45):32766-76. | ||||
REF 28 | Comprehensive identification of substrates for F-box proteins by differential proteomics analysis. J Proteome Res. 2012 Jun 1;11(6):3175-85. | ||||
REF 29 | Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation. Oncotarget. 2017 Aug 24;8(48):84193-84203. | ||||
REF 30 | Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex. Oncogene. 2013 Jan 3;32(1):78-85. | ||||
REF 31 | The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Biol Chem. 2003 Aug 15;278(33):30854-8. | ||||
REF 32 | Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 1998 Jan 15;17(2):368-83. | ||||
REF 33 | Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res. 2011 May;21(5):754-69. | ||||
REF 34 | Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry. J Mol Biol. 2006 Oct 27;363(3):673-86. | ||||
REF 35 | von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage. Oncogene. 2011 Jul 14;30(28):3127-38. | ||||
REF 36 | Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013 Aug 1;154(3):556-68. | ||||
REF 37 | Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1649-54. | ||||
REF 38 | Atorvastatin prevents endothelial dysfunction in high glucose condition through Skp2-mediated degradation of FOXO1 and ICAM-1. Biochem Biophys Res Commun. 2018 Jan 8;495(2):2050-2057. | ||||
REF 39 | The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell. 2003 May;11(5):1189-200. | ||||
REF 40 | Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway. Oncogene. 2005 Nov 3;24(48):7238-47. | ||||
REF 41 | Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene. 2012 Mar 22;31(12):1546-57. | ||||
REF 42 | Photoactivatable protein labeling by singlet oxygen mediated reactions. Bioorg Med Chem Lett. 2016 Jul 15;26(14):3359-3363. | ||||
REF 43 | An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell. 2004 Oct 8;16(1):47-58. | ||||
REF 44 | Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors. Oncotarget. 2015 Oct 27;6(33):34953-67. | ||||
REF 45 | Specific small molecule inhibitors of Skp2-mediated p27 degradation. Chem Biol. 2012 Dec 21;19(12):1515-24. | ||||
REF 46 | Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol Cell Biol. 2004 Oct;24(20):8951-62. | ||||
REF 47 | Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development. Mol Cell Biol. 2009 Jul;29(13):3529-43. | ||||
REF 48 | Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment. J Cell Sci. 2013 Oct 15;126(Pt 20):4636-46. | ||||
REF 49 | p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J Biol Chem. 2004 Jun 11;279(24):25260-7. | ||||
REF 50 | Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 2001 Sep 20;413(6853):316-22. | ||||
REF 51 | Structural basis for a reciprocal regulation between SCF and CSN. Cell Rep. 2012 Sep 27;2(3):616-27. | ||||
REF 52 | A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1. J Biol Chem. 2003 Aug 22;278(34):32390-6. | ||||
REF 53 | A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell. 2001 Mar;7(3):639-50. | ||||
REF 54 | Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening. Cancer Sci. 2013 Nov;104(11):1461-7. | ||||
REF 55 | Histidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and Src. J Biol Chem. 2009 Feb 20;284(8):5265-76. | ||||
REF 56 | APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell. 2007 Aug 3;27(3):462-73. | ||||
REF 57 | UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell. 2003 Sep 5;114(5):599-610. | ||||
REF 58 | PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008 Sep 15;22(18):2496-506. | ||||
REF 59 | Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2. J Biol Chem. 2005 Aug 26;280(34):30301-9. | ||||
REF 60 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 61 | Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res. 2008 Jun 1;68(11):4192-200. | ||||
REF 62 | Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase. J Biol Chem. 2007 May 25;282(21):15462-70. | ||||
REF 63 | The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol. 2001 Mar;3(3):321-4. | ||||
REF 64 | Three different binding sites of Cks1 are required for p27-ubiquitin ligation. J Biol Chem. 2002 Nov 1;277(44):42233-40. | ||||
REF 65 | High-throughput screening for inhibitors of the Cks1-Skp2 interaction. Methods Enzymol. 2005;399:717-28. | ||||
REF 66 | Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1. Exp Cell Res. 2009 Nov 1;315(18):3152-62. | ||||
REF 67 | Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing TrCP. Biol Pharm Bull. 2012;35(9):1539-45. | ||||
REF 68 | Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. J Biol Chem. 2004 Apr 23;279(17):17283-8. | ||||
REF 69 | Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. J Cell Physiol. 2011 Feb;226(2):407-13. | ||||
REF 70 | Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10231-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.